Edgewise Therapeutics
EWTX
EWTX
94 hedge funds and large institutions have $505M invested in Edgewise Therapeutics in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 21 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
21% more funds holding
Funds holding: 78 → 94 (+16)
4.52% more ownership
Funds ownership: 102.8% → 107.31% (+4.5%)
Holders
94
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$50.8M | |
| 2 | +$33.2M | |
| 3 | +$16.5M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$14.5M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$11.2M |
Top Sellers
| 1 | -$7.85M | |
| 2 | -$2.28M | |
| 3 | -$2.05M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$1.19M |
| 5 |
Bank of New York Mellon
New York
|
-$919K |